Role of Population Pharmacokinetics in Drug Development
- 1 April 1997
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 32 (4) , 294-312
- https://doi.org/10.2165/00003088-199732040-00003
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Identification of Patients with Impaired Hepatic Drug Metabolism Using a Limited Sampling Procedure for Estimation of Phenazone (Antipyrine) Pharmacokinetic ParametersClinical Pharmacokinetics, 1993
- Evaluation of Bayesian estimation in comparison to NONMEM for population pharmacokinetic data analysis: Application to pefloxacin in intensive care unit patientsJournal of Pharmacokinetics and Biopharmaceutics, 1992
- Population Pharmacokinetics of GentamicinClinical Pharmacokinetics, 1992
- Pharmacokinetics of Quinidine in Male PatientsClinical Pharmacokinetics, 1992
- Pharmacokinetics of the Digoxin-Quinidine Interaction via Mixed-Effect ModellingClinical Pharmacokinetics, 1992
- A population analysis of the pharmacokinetics and pharmacodynamics of midazolam in the ratJournal of Pharmacokinetics and Biopharmaceutics, 1991
- Application of NONMEM to routine bioavailability dataJournal of Pharmacokinetics and Biopharmaceutics, 1990
- Population PharmacokineticsClinical Pharmacokinetics, 1986
- Optimal sampling times for pharmacokinetic experimentsJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977